Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

56.25USD
2 Dec 2016
Change (% chg)

$1.36 (+2.48%)
Prev Close
$54.89
Open
$54.87
Day's High
$56.73
Day's Low
$54.37
Volume
892,820
Avg. Vol
1,084,590
52-wk High
$80.71
52-wk Low
$27.14

Cooke, Shane 

Mr. Shane Cooke is President of Alkermes Plc. He is employed by Alkermes Pharma Ireland Limited, an Irish subsidiary of the Company. From May 2005 to September 16, 2011, Mr. Cooke served as a Director of Elan Corporation, plc ("Elan"). From May 2007 to September 16, 2011, Mr. Cooke was Executive Vice President of Elan and Head of EDT. Mr. Cooke served as the Chief Financial Officer of Elan from July 2001, when he joined Elan, until May 2011. Prior to joining Elan, Mr. Cooke was Chief Executive of Pembroke Capital Limited, an aviation leasing company, and prior to that, held a number of senior positions in finance in the banking and aviation industries. He is a chartered accountant. He is currently on the board of directors of Prothena Corporation plc and Endo International plc, both publicly traded companies, and Onclave and Neotope, both privately held companies.

Basic Compensation

Total Annual Compensation, USD 630,583
Restricted Stock Awards, USD 990,360
Long-Term Incentive Plans, USD --
All Other, USD 3,026,020
Fiscal Year Total, USD 4,646,970

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

10,448,400

Shane Cooke

4,646,970

James Frates

2,565,400

Gordon Pugh

1,965,720

Kathryn Biberstein

3,041,000

Elliot Ehrich

3,188,760
As Of  30 Dec 2014